<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37010807</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-1182</ISSN><JournalIssue CitedMedium="Internet"><Volume>60</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Molecular neurobiology</Title><ISOAbbreviation>Mol Neurobiol</ISOAbbreviation></Journal><ArticleTitle>Inflammasome-Mediated Neuronal-Microglial Crosstalk: a Therapeutic Substrate for the Familial C9orf72 Variant of Frontotemporal Dementia/Amyotrophic Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>4004</StartPage><EndPage>4016</EndPage><MedlinePgn>4004-4016</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12035-023-03315-w</ELocationID><Abstract><AbstractText>Intronic G<sub>4</sub>C<sub>2</sub> hexanucleotide repeat expansions (HRE) of C9orf72 are the most common cause of familial variants of frontotemporal dementia/amyotrophic lateral sclerosis (FTD/ALS). G<sub>4</sub>C<sub>2</sub> HREs in C9orf72 undergo non-canonical repeat-associated translation, producing dipeptide repeat (DPR) proteins, with various deleterious impacts on cellular homeostasis. While five different DPRs are produced, poly(glycine-arginine) (GR) is amongst the most toxic and is the only DPR to accumulate in the associated clinically relevant anatomical locations of the brain. Previous work has demonstrated the profound effects of a poly (GR) model of C9orf72 FTD/ALS, including motor impairment, memory deficits, neurodegeneration, and neuroinflammation. Neuroinflammation is hypothesized to be a driving factor in the disease course; microglia activation is present prior to symptom onset and persists throughout the disease. Here, using an established mouse model of C9orf72 FTD/ALS, we investigate the contributions of the nod-like receptor pyrin-containing 3 (NLRP3) inflammasome in the pathogenesis of FTD/ALS. We find that inflammasome-mediated neuroinflammation is increased with microglial activation, cleavage of caspase-1, production of IL-1&#x3b2;, and upregulation of Cxcl10 in the brain of C9orf72 FTD/ALS mice. Excitingly, we find that genetic ablation of Nlrp3 significantly improved survival, protected behavioral deficits, and prevented neurodegeneration suggesting a novel mechanism involving HRE-mediated induction of innate immunity. The findings provide experimental evidence of the integral role of HRE in inflammasome-mediated innate immunity in the C9orf72 variant of FTD/ALS pathogenesis and suggest the NLRP3 inflammasome as a therapeutic target.</AbstractText><CopyrightInformation>&#xa9; 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Trageser</LastName><ForeName>Kyle J</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Eun-Jeong</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Chad</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iban-Arias</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oguchi</LastName><ForeName>Tatsunori</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sebastian-Valverde</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iqbal</LastName><ForeName>Umar Haris</ForeName><Initials>UH</Initials><AffiliationInfo><Affiliation>Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Henry</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Estill</LastName><ForeName>Molly</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Rahim</LastName><ForeName>Md</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raval</LastName><ForeName>Urdhva</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herman</LastName><ForeName>Francis J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yong Jie</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL, 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petrucelli</LastName><ForeName>Leonard</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL, 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasinetti</LastName><ForeName>Giulio Maria</ForeName><Initials>GM</Initials><Identifier Source="ORCID">0000-0002-1524-5196</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. giulio.pasinetti@mssm.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Geriatric Research, Education and Clinical Center, James J. Peters Veterans Affairs Medical Center, Bronx, NY, 10468, USA. giulio.pasinetti@mssm.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U19AT010835</GrantID><Acronym>AT</Acronym><Agency>NCCIH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19AT010835</GrantID><Acronym>AT</Acronym><Agency>NCCIH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Neurobiol</MedlineTA><NlmUniqueID>8900963</NlmUniqueID><ISSNLinking>0893-7648</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058847">Inflammasomes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071199">NLR Family, Pyrin Domain-Containing 3 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004151">Dipeptides</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C566288">Frontotemporal Dementia With Motor Neuron Disease</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058847" MajorTopicYN="N">Inflammasomes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071199" MajorTopicYN="N">NLR Family, Pyrin Domain-Containing 3 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000090862" MajorTopicYN="N">Neuroinflammatory Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042622" MajorTopicYN="N">DNA Repeat Expansion</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004151" MajorTopicYN="N">Dipeptides</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">C9orf72</Keyword><Keyword MajorTopicYN="N">Frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">Inflammasome</Keyword><Keyword MajorTopicYN="N">Microglia</Keyword><Keyword MajorTopicYN="N">Neurodegeneration</Keyword><Keyword MajorTopicYN="N">Neuroinflammation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>3</Day><Hour>11</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37010807</ArticleId><ArticleId IdType="doi">10.1007/s12035-023-03315-w</ArticleId><ArticleId IdType="pii">10.1007/s12035-023-03315-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ, Simmons Z et al (2017) Amyotrophic lateral sclerosis. Nat Rev Dis Primers 3:17071. https://doi.org/10.1038/nrdp.2017.71</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H et al (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72(2):257&#x2013;268. https://doi.org/10.1016/j.neuron.2011.09.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId><ArticleId IdType="pmc">3200438</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA et al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72(2):245&#x2013;256. https://doi.org/10.1016/j.neuron.2011.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId><ArticleId IdType="pmc">3202986</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakae N, Bieniek KF, Zhang YJ, Ross K, Gendron TF, Murray ME, Rademakers R, Petrucelli L et al (2018) Poly-GR dipeptide repeat polymers correlate with neurodegeneration and clinicopathological subtypes in C9ORF72-related brain disease. Acta Neuropathol Commun 6(1):63. https://doi.org/10.1186/s40478-018-0564-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0564-7</ArticleId><ArticleId IdType="pubmed">30029693</ArticleId><ArticleId IdType="pmc">6054740</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew J, Cook C, Gendron TF, Jansen-West K, Del Rosso G, Daughrity LM, Castanedes-Casey M, Kurti A et al (2019) Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy. Mol Neurodegener 14(1):9. https://doi.org/10.1186/s13024-019-0310-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-019-0310-z</ArticleId><ArticleId IdType="pubmed">30767771</ArticleId><ArticleId IdType="pmc">6377782</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan G, Raitcheva D, Bartlett D, Prudencio M, McKenna-Yasek DM, Douthwright C, Oskarsson BE, Ladha S et al (2022) Poly(GR) and poly(GA) in cerebrospinal fluid as potential biomarkers for C9ORF72-ALS/FTD. Nat Commun 13(1):2799. https://doi.org/10.1038/s41467-022-30387-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30387-4</ArticleId><ArticleId IdType="pubmed">35589711</ArticleId><ArticleId IdType="pmc">9119980</ArticleId></ArticleIdList></Reference><Reference><Citation>Gascon E, Gao FB (2014) The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders. J Neurogenet 28(1&#x2013;2):30&#x2013;40. https://doi.org/10.3109/01677063.2013.876021</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/01677063.2013.876021</ArticleId><ArticleId IdType="pubmed">24506814</ArticleId><ArticleId IdType="pmc">4199862</ArticleId></ArticleIdList></Reference><Reference><Citation>Moisse K, Strong MJ (2006) Innate immunity in amyotrophic lateral sclerosis. Biochim Biophys Acta 1762(11&#x2013;12):1083&#x2013;1093. https://doi.org/10.1016/j.bbadis.2006.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2006.03.001</ArticleId><ArticleId IdType="pubmed">16624536</ArticleId></ArticleIdList></Reference><Reference><Citation>Trageser KJ, Smith C, Herman FJ, Ono K, Pasinetti GM (2019) Mechanisms of immune activation by c9orf72-expansions in amyotrophic lateral sclerosis and frontotemporal dementia. Front Neurosci 13:1298. https://doi.org/10.3389/fnins.2019.01298</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01298</ArticleId><ArticleId IdType="pubmed">31920478</ArticleId><ArticleId IdType="pmc">6914852</ArticleId></ArticleIdList></Reference><Reference><Citation>Ising C, Heneka MT (2018) Functional and structural damage of neurons by innate immune mechanisms during neurodegeneration. Cell Death Dis 9(2):120. https://doi.org/10.1038/s41419-017-0153-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-017-0153-x</ArticleId><ArticleId IdType="pubmed">29371603</ArticleId><ArticleId IdType="pmc">5833757</ArticleId></ArticleIdList></Reference><Reference><Citation>Herman FJ, Pasinetti GM (2018) Principles of inflammasome priming and inhibition: Implications for psychiatric disorders. Brain Behav Immun 73:66&#x2013;84. https://doi.org/10.1016/j.bbi.2018.06.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2018.06.010</ArticleId><ArticleId IdType="pubmed">29902514</ArticleId><ArticleId IdType="pmc">6526722</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman L, Guo H, David CN, Brickey WJ, Jha S, Ting JP (2017) NLR members NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes. J Exp Med 214(5):1351&#x2013;1370. https://doi.org/10.1084/jem.20150237</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20150237</ArticleId><ArticleId IdType="pubmed">28404595</ArticleId><ArticleId IdType="pmc">5413320</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu LY, Liu C, Li ZR, Niu C, Wu J (2021) NLRP3 deficiency did not attenuate NASH development under high fat calorie diet plus high fructose and glucose in drinking water. Lab Invest 101(5):588&#x2013;599. https://doi.org/10.1038/s41374-021-00535-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41374-021-00535-3</ArticleId><ArticleId IdType="pubmed">36775381</ArticleId></ArticleIdList></Reference><Reference><Citation>Glascock JJ, Osman EY, Coady TH, Rose FF, Shababi M, Lorson CL (2011) Delivery of therapeutic agents through intracerebroventricular (ICV) and intravenous (IV) injection in mice. J Vis Exp (56). https://doi.org/10.3791/2968</Citation></Reference><Reference><Citation>Cook C, Petrucelli L (2019) Genetic convergence brings clarity to the enigmatic red line in ALS. Neuron 101(6):1057&#x2013;1069. https://doi.org/10.1016/j.neuron.2019.02.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.02.032</ArticleId><ArticleId IdType="pubmed">30897357</ArticleId></ArticleIdList></Reference><Reference><Citation>Seibenhener ML, Wooten MC (2015) Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice. J Vis Exp (96):e52434. https://doi.org/10.3791/52434</Citation></Reference><Reference><Citation>Aartsma-Rus A, van Putten M (2014) Assessing functional performance in the mdx mouse model. J Vis Exp (85). https://doi.org/10.3791/51303</Citation></Reference><Reference><Citation>Saura J, Tusell JM, Serratosa J (2003) High-yield isolation of murine microglia by mild trypsinization. Glia 44(3):183&#x2013;189. https://doi.org/10.1002/glia.10274</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.10274</ArticleId><ArticleId IdType="pubmed">14603460</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25(4):402&#x2013;408. https://doi.org/10.1006/meth.2001.1262</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId><ArticleId IdType="pubmed">11846609</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden TL (2012) Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics 13:134. https://doi.org/10.1186/1471-2105-13-134</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-13-134</ArticleId><ArticleId IdType="pubmed">22708584</ArticleId><ArticleId IdType="pmc">3412702</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, Griep A, Axt D et al (2013) NLRP3 is activated in Alzheimer&#x2019;s disease and contributes to pathology in APP/PS1 mice. Nature 493(7434):674&#x2013;678. https://doi.org/10.1038/nature11729</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11729</ArticleId><ArticleId IdType="pubmed">23254930</ArticleId></ArticleIdList></Reference><Reference><Citation>Su W, Kang J, Sopher B, Gillespie J, Aloi MS, Odom GL, Hopkins S, Case A et al (2016) Recombinant adeno-associated viral (rAAV) vectors mediate efficient gene transduction in cultured neonatal and adult microglia. J Neurochem 136(Suppl 1):49&#x2013;62. https://doi.org/10.1111/jnc.13081</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13081</ArticleId><ArticleId IdType="pubmed">25708596</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacroix A, Toussay X, Anenberg E, Lecrux C, Ferreiros N, Karagiannis A, Plaisier F, Chausson P et al (2015) COX-2-derived prostaglandin E2 produced by pyramidal neurons contributes to neurovascular coupling in the rodent cerebral cortex. J Neurosci 35(34):11791&#x2013;11810. https://doi.org/10.1523/JNEUROSCI.0651-15.2015</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0651-15.2015</ArticleId><ArticleId IdType="pubmed">26311764</ArticleId><ArticleId IdType="pmc">6705452</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P, Tauber C, Vercoullie J, Arlicot N, Prunier C, Praline J, Nicolas G, Venel Y et al (2012) Molecular imaging of microglial activation in amyotrophic lateral sclerosis. PLoS One 7(12):e52941. https://doi.org/10.1371/journal.pone.0052941</Citation></Reference><Reference><Citation>Zhang YJ, Gendron TF, Ebbert MTW, O&#x2019;Raw AD, Yue M, Jansen-West K, Zhang X, Prudencio M et al (2018) Poly(GR) impairs protein translation and stress granule dynamics in C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis. Nat Med 24(8):1136&#x2013;1142. https://doi.org/10.1038/s41591-018-0071-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0071-1</ArticleId><ArticleId IdType="pubmed">29942091</ArticleId><ArticleId IdType="pmc">6520050</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarner T, Janssen K, Nellessen L, Stangel M, Skripuletz T, Krauspe B, Hess FM, Denecke B et al (2015) CXCL10 triggers early microglial activation in the cuprizone model. J Immunol 194(7):3400&#x2013;3413. https://doi.org/10.4049/jimmunol.1401459</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1401459</ArticleId><ArticleId IdType="pubmed">25725102</ArticleId></ArticleIdList></Reference><Reference><Citation>McGeough MD, Wree A, Inzaugarat ME, Haimovich A, Johnson CD, Pena CA, Goldbach-Mansky R, Broderick L et al (2017) TNF regulates transcription of NLRP3 inflammasome components and inflammatory molecules in cryopyrinopathies. J Clin Invest 127(12):4488&#x2013;4497. https://doi.org/10.1172/JCI90699</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI90699</ArticleId><ArticleId IdType="pubmed">29130929</ArticleId><ArticleId IdType="pmc">5707143</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Wang F, Hu Y, Chen R, Meng D, Guo L, Lv H, Guan J et al (2020) In vivo stress granule misprocessing evidenced in a FUS knock-in ALS mouse model. Brain 143(5):1350&#x2013;1367. https://doi.org/10.1093/brain/awaa076</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa076</ArticleId><ArticleId IdType="pubmed">32358598</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters OM, Ghasemi M, Brown RH Jr (2015) Emerging mechanisms of molecular pathology in ALS. J Clin Invest 125(5):1767&#x2013;1779. https://doi.org/10.1172/JCI71601</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI71601</ArticleId><ArticleId IdType="pubmed">25932674</ArticleId><ArticleId IdType="pmc">4463186</ArticleId></ArticleIdList></Reference><Reference><Citation>Thonhoff JR, Simpson EP, Appel SH (2018) Neuroinflammatory mechanisms in amyotrophic lateral sclerosis pathogenesis. Curr Opin Neurol 31(5):635&#x2013;639. https://doi.org/10.1097/WCO.0000000000000599</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000599</ArticleId><ArticleId IdType="pubmed">30048339</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Z, Pan YT, Zhang ZY, Yang H, Yu SY, Zheng Y, Ma JH, Wang XM (2020) Systemic activation of NLRP3 inflammasome and plasma alpha-synuclein levels are correlated with motor severity and progression in Parkinson&#x2019;s disease. J Neuroinflammation 17(1):11. https://doi.org/10.1186/s12974-019-1670-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1670-6</ArticleId><ArticleId IdType="pubmed">31915018</ArticleId><ArticleId IdType="pmc">6950934</ArticleId></ArticleIdList></Reference><Reference><Citation>Malhotra S, Costa C, Eixarch H, Keller CW, Amman L, Martinez-Banaclocha H, Midaglia L, Sarro E et al (2020) NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients. Brain 143(5):1414&#x2013;1430. https://doi.org/10.1093/brain/awaa084</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa084</ArticleId><ArticleId IdType="pubmed">32282893</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanagi T, Yuasa S, Nakamura Y, Suzuki E, Aoki M, Warita H, Itoyama Y, Uchino S et al (2010) Appearance of phagocytic microglia adjacent to motoneurons in spinal cord tissue from a presymptomatic transgenic rat model of amyotrophic lateral sclerosis. J Neurosci Res 88(12):2736&#x2013;2746. https://doi.org/10.1002/jnr.22424</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.22424</ArticleId><ArticleId IdType="pubmed">20648658</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R, Yang B, Zhang D (2011) Activation of interferon signaling pathways in spinal cord astrocytes from an ALS mouse model. Glia 59(6):946&#x2013;958. https://doi.org/10.1002/glia.21167</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.21167</ArticleId><ArticleId IdType="pubmed">21446050</ArticleId><ArticleId IdType="pmc">3077460</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Goldacre R, Ramagopalan S, Talbot K, Goldacre MJ (2013) Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study. Neurology 81(14):1222&#x2013;1225. https://doi.org/10.1212/WNL.0b013e3182a6cc13</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182a6cc13</ArticleId><ArticleId IdType="pubmed">23946298</ArticleId><ArticleId IdType="pmc">3795611</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Cagnin A, Turkheimer FE, Miller CC, Shaw CE, Brooks DJ, Leigh PN, Banati RB (2004) Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis 15(3):601&#x2013;609. https://doi.org/10.1016/j.nbd.2003.12.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2003.12.012</ArticleId><ArticleId IdType="pubmed">15056468</ArticleId></ArticleIdList></Reference><Reference><Citation>Baron R, Babcock AA, Nemirovsky A, Finsen B, Monsonego A (2014) Accelerated microglial pathology is associated with Abeta plaques in mouse models of Alzheimer&#x2019;s disease. Aging Cell 13(4):584&#x2013;595. https://doi.org/10.1111/acel.12210</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.12210</ArticleId><ArticleId IdType="pubmed">24641683</ArticleId><ArticleId IdType="pmc">4326940</ArticleId></ArticleIdList></Reference><Reference><Citation>Debye B, Schmulling L, Zhou L, Rune G, Beyer C, Johann S (2018) Neurodegeneration and NLRP3 inflammasome expression in the anterior thalamus of SOD1(G93A) ALS mice. Brain Pathol 28(1):14&#x2013;27. https://doi.org/10.1111/bpa.12467</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12467</ArticleId><ArticleId IdType="pubmed">27880990</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Garcia L, Miana-Mena FJ, Moreno-Martinez L, de la Torre M, Lunetta C, Tarlarini C, Zaragoza P, Calvo AC et al (2021) Inflammasome in ALS skeletal muscle: NLRP3 as a potential biomarker. Int J Mol Sci 22(5). https://doi.org/10.3390/ijms22052523</Citation></Reference><Reference><Citation>Johann S, Heitzer M, Kanagaratnam M, Goswami A, Rizo T, Weis J, Troost D, Beyer C (2015) NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients. Glia 63(12):2260&#x2013;2273. https://doi.org/10.1002/glia.22891</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22891</ArticleId><ArticleId IdType="pubmed">26200799</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein RS, Lin E, Zhang B, Luster AD, Tollett J, Samuel MA, Engle M, Diamond MS (2005) Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J Virol 79(17):11457&#x2013;11466. https://doi.org/10.1128/JVI.79.17.11457-11466.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.17.11457-11466.2005</ArticleId><ArticleId IdType="pubmed">16103196</ArticleId><ArticleId IdType="pmc">1193600</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S (2010) Endoplasmic reticulum stress in motor neurons of the spinal cord in sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 69(4):346&#x2013;355. https://doi.org/10.1097/NEN.0b013e3181d44992</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3181d44992</ArticleId><ArticleId IdType="pubmed">20448480</ArticleId></ArticleIdList></Reference><Reference><Citation>Perner C, Perner F, Stubendorff B, Forster M, Witte OW, Heidel FH, Prell T, Grosskreutz J (2018) Dysregulation of chemokine receptor expression and function in leukocytes from ALS patients. J Neuroinflammation 15(1):99. https://doi.org/10.1186/s12974-018-1135-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1135-3</ArticleId><ArticleId IdType="pubmed">29592817</ArticleId><ArticleId IdType="pmc">5874995</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>